Synthetic plasmodium antigens, compositions, and uses thereof

US12404311B2 · kind B2 · utility

Assignees

• University of South Florida · US
• CASE WESTERN RESERVE UNIVERSITY · US
• Washington University · US

Inventors

• John H. Adams · Tampa, US
• Christopher L. King · Moreland Hills, US
• Niraj H. Tolia · Chesterfield, US
• Edwin Chen · Chesterfield, US
• Nichole Diane Salinas · Chesterfield, US
• Miriam Thankam George · Nilgrar, IN
• Francis B. Ntumngia · Tampa, US
• Samantha Jones Barnes · Tampa, US

Key dates

• Filing date: Sep 19, 2023
• Grant date: Sep 2, 2025
• Expiry date: Sep 19, 2043

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Provided herein are synthetic P. vivax antigens, antibodies and pharmaceutical formulations and vaccines thereof. Also provided herein are methods of treating and/or preventing Plasmodium infection and/or disease by administering the synthetic P. vivax antigens, antibodies and pharmaceutical formulations and vaccines thereof.